Insight into the mechanism of action of the SSB interactome
深入了解 SSB 相互作用组的作用机制
基本信息
- 批准号:10574583
- 负责人:
- 金额:$ 31.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-16 至 2026-01-31
- 项目状态:未结题
- 来源:
- 关键词:AffinityBRCA2 geneBindingBinding ProteinsBiochemistryBiological AssayBiological ModelsBiologyC-terminal binding proteinCaringCell DeathComplexCreativenessCryoelectron MicroscopyCrystallographyDNADNA BindingDNA biosynthesisDNA metabolismDNA-Binding ProteinsDNA-Directed DNA PolymeraseDataDefectDevelopmentDisparateElementsEnzyme KineticsEscherichia coliEukaryotaEventFamilyFamily memberFosteringGeneticGenetic RecombinationGenomeGenome StabilityGoalsHealthIn VitroKineticsLeadLengthMaintenanceMalignant NeoplasmsMediatingMissionMolecularMultiple PartnersMutationOligonucleotidesOligosaccharidesOrganismOutcomePlayProkaryotic CellsProteinsPublic HealthPublishingReactionReplication-Associated ProcessResearchRoleSS DNA BPSingle-Stranded DNAStructureSystemTailTestingTimeUnited States National Institutes of HealthWorkcombinatorialgenome integrityhelicasehuman diseaseimprovedin vivoinnovationinsightmembernovelprotein Bprotein functionpublic health relevancerepairedsingle moleculesuperresolution microscopy
项目摘要
ABSTRACT
The single-stranded DNA binding protein (SSB) is the founding member of the nineteen-partner SSB interactome. There is
a fundamental gap in understanding the mechanism of action of the interactome, the first prokaryotic family of
oligosaccharide/oligonucleotide binding fold (OB-fold) genome guardians identified. The continued existence of this gap
represents an important problem because, until it is filled, a complete and clear understanding of genome stability will be
lacking. This understanding is crucial as defects in OB-fold genome guardian family members have disastrous consequences
for genome stability. In higher organisms, mutations in the three OB-folds of BRCA2 ultimately result in cancer, and the
proposed studies are therefore directly relevant to human disease. Consequently, the long-term goal is to understand the
molecular mechanism of the SSB interactome. The main objective of this proposal is to understand how SSB interacts with,
and regulates, several partner proteins and itself, to maintain genome integrity. The central hypothesis is that two regions
of SSB known as the linker and the OB-fold, (present in both SSB and interactome partners), are the key elements to all
aspects of protein function. The rationale for the proposed research is that once it is known how SSB physically and
functionally interacts with both itself and its partners, a clearer understanding of the events required to maintain genome
integrity, mediated by this OB-fold family of genome guardians, will be obtained. The central hypothesis will be tested by
pursuing two specific aims: 1) determine the role of the linker/OB-fold network in SSB function; and 2) determine the
mechanism of action of the SSB interactome. Under the first aim, a combination of in vivo and in vitro binding assays,
HDX-MS, protein crystallography, cryo-EM, and single-molecule biochemistry will be used to determine whether the
linker/OB-fold interface is the primary means of SSB-partner binding. Under the second aim, enzyme kinetics, genetics,
real-time super-resolution microscopy, and single-molecule biochemistry will be used to understand how the linker/OB-
fold network mediates SSB interactome function in the dynamic reactions of DNA replication, recombination, and repair.
The proposed research is innovative because of the combinatorial strategy taken, the novel single-molecule approaches
used, and the care that we will take in elucidating SSB interactome function using full-length proteins. The proposed
research is significant because it will allow, for the first time, the development of a clear picture of SSB interactome function
in DNA metabolism and the maintenance of genome integrity.
抽象的
单链 DNA 结合蛋白 (SSB) 是十九个伙伴 SSB 相互作用组的创始成员。有
在理解相互作用组(第一个原核生物家族)的作用机制方面存在根本差距
鉴定出寡糖/寡核苷酸结合折叠(OB折叠)基因组守护者。这种差距的持续存在
代表了一个重要的问题,因为在它被填补之前,对基因组稳定性的完整和清晰的理解将是
缺乏。这种理解至关重要,因为 OB 折叠基因组监护家庭成员的缺陷会带来灾难性的后果
为了基因组的稳定性。在高等生物中,BRCA2 的三个 OB 折叠的突变最终会导致癌症,并且
因此,拟议的研究与人类疾病直接相关。因此,长期目标是了解
SSB相互作用组的分子机制。该提案的主要目标是了解 SSB 如何与以下对象交互:
并调节一些伙伴蛋白及其自身,以维持基因组完整性。中心假设是两个区域
称为连接子的 SSB 和 OB 折叠(存在于 SSB 和相互作用组伙伴中)是所有
蛋白质功能的各个方面。拟议研究的基本原理是,一旦了解 SSB 的物理和
与自身及其伙伴进行功能性相互作用,更清楚地了解维持基因组所需的事件
由基因组守护者的 OB 折叠家族介导的完整性将被获得。中心假设将被检验
追求两个具体目标:1)确定连接子/OB折叠网络在SSB功能中的作用; 2) 确定
SSB 相互作用组的作用机制。第一个目标是结合体内和体外结合测定,
HDX-MS、蛋白质晶体学、冷冻电镜和单分子生物化学将用于确定是否
连接子/OB折叠界面是SSB-伙伴结合的主要方式。在第二个目标下,酶动力学、遗传学、
实时超分辨率显微镜和单分子生物化学将用于了解连接器/OB-
折叠网络在 DNA 复制、重组和修复的动态反应中介导 SSB 相互作用组功能。
由于所采取的组合策略、新颖的单分子方法,所提出的研究具有创新性
以及我们在使用全长蛋白质阐明 SSB 相互作用组功能时所采取的谨慎态度。拟议的
研究意义重大,因为它将首次使我们能够清晰地了解 SSB 相互作用组功能
DNA 代谢和基因组完整性的维护。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ram I. Mahato其他文献
Physicochemical and pharmacokinetic characteristics of plasmid DNA/cationic liposome complexes.
质粒 DNA/阳离子脂质体复合物的理化和药代动力学特征。
- DOI:
10.1002/jps.2600841102 - 发表时间:
1995-11-01 - 期刊:
- 影响因子:3.8
- 作者:
Ram I. Mahato;Kenji Kawabata;T. Nomura;Y. Takakura;Mitsuru Hashida - 通讯作者:
Mitsuru Hashida
Pharmaceutical perspectives of nonviral gene therapy.
非病毒基因治疗的药学观点。
- DOI:
10.1016/s0065-2660(08)60152-2 - 发表时间:
1999-09-14 - 期刊:
- 影响因子:0
- 作者:
Ram I. Mahato;Louis C. Smith;Alain Roll - 通讯作者:
Alain Roll
Natural killer cells for pancreatic cancer immunotherapy: Role of nanoparticles.
胰腺癌免疫治疗的自然杀伤细胞:纳米颗粒的作用。
- DOI:
10.1016/j.canlet.2023.216462 - 发表时间:
2023-11-01 - 期刊:
- 影响因子:9.7
- 作者:
Virender Kumar;Ram I. Mahato - 通讯作者:
Ram I. Mahato
pH-sensitive cationic polymer gene delivery vehicle: N-Ac-poly(L-histidine)-graft-poly(L-lysine) comb shaped polymer.
pH敏感的阳离子聚合物基因递送载体:N-Ac-聚(L-组氨酸)-接枝-聚(L-赖氨酸)梳状聚合物。
- DOI:
10.1021/bc0000177 - 发表时间:
2000-09-18 - 期刊:
- 影响因子:4.7
- 作者:
Jonathan M. Benns;Joon;Ram I. Mahato;Jong;Sung Wan Kim - 通讯作者:
Sung Wan Kim
Therapeutic perspectives on PDE4B inhibition in adipose tissue dysfunction and chronic liver injury.
PDE4B 抑制对脂肪组织功能障碍和慢性肝损伤的治疗前景。
- DOI:
10.1080/14728222.2024.2369590 - 发表时间:
2024-06-15 - 期刊:
- 影响因子:5.8
- 作者:
Dalton W. Staller;Robert G Bennett;Ram I. Mahato - 通讯作者:
Ram I. Mahato
Ram I. Mahato的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ram I. Mahato', 18)}}的其他基金
Development and Preclinical Evaluation of Nanoformulations in Liver Fibrotic Mice
肝纤维化小鼠纳米制剂的开发和临床前评价
- 批准号:
10639037 - 财政年份:2023
- 资助金额:
$ 31.19万 - 项目类别:
Nanomedicine of Hedgehog and AKT/ERK Dual Inhibitors for Pancreatic Cancer
Hedgehog和AKT/ERK双重抑制剂治疗胰腺癌的纳米药物
- 批准号:
10346555 - 财政年份:2022
- 资助金额:
$ 31.19万 - 项目类别:
Lipid nanomedicine targeting multiple signaling pathways of medulloblastoma
靶向髓母细胞瘤多种信号通路的脂质纳米药物
- 批准号:
10504006 - 财政年份:2022
- 资助金额:
$ 31.19万 - 项目类别:
Lipid nanomedicine targeting multiple signaling pathways of medulloblastoma
靶向髓母细胞瘤多种信号通路的脂质纳米药物
- 批准号:
10663377 - 财政年份:2022
- 资助金额:
$ 31.19万 - 项目类别:
Lipid nanomedicine targeting multiple signaling pathways of medulloblastoma
靶向髓母细胞瘤多种信号通路的脂质纳米药物
- 批准号:
10663377 - 财政年份:2022
- 资助金额:
$ 31.19万 - 项目类别:
Nanomedicine of Hedgehog and AKT/ERK Dual Inhibitors for Pancreatic Cancer
Hedgehog和AKT/ERK双重抑制剂治疗胰腺癌的纳米药物
- 批准号:
10555244 - 财政年份:2022
- 资助金额:
$ 31.19万 - 项目类别:
Research and Development of Novel Drug Delivery Systems Symposium
新型给药系统研发研讨会
- 批准号:
8907150 - 财政年份:2015
- 资助金额:
$ 31.19万 - 项目类别:
Polymeric Nanomedicines of Small Molecules and miRNA for Treating Pancreatic Canc
用于治疗胰腺癌的小分子和 miRNA 聚合纳米药物
- 批准号:
8761405 - 财政年份:2014
- 资助金额:
$ 31.19万 - 项目类别:
Polymeric Nanomedicines of Small Molecules and miRNA for Treating Pancreatic Canc
用于治疗胰腺癌的小分子和 miRNA 聚合纳米药物
- 批准号:
9298650 - 财政年份:2014
- 资助金额:
$ 31.19万 - 项目类别:
Targeted Delivery of TFOs for Treatment of Liver Fibrosis
TFO 靶向递送治疗肝纤维化
- 批准号:
7747940 - 财政年份:2007
- 资助金额:
$ 31.19万 - 项目类别:
相似国自然基金
DNA同源重组基因EXO1和BRCA2在早发性卵巢功能不全发病中的作用和致病机制研究
- 批准号:
- 批准年份:2020
- 资助金额:58 万元
- 项目类别:面上项目
BRCA2基因新突变导致的甲基缺失引起高危家族卵巢/乳腺癌发生的机制研究
- 批准号:81972444
- 批准年份:2019
- 资助金额:55 万元
- 项目类别:面上项目
中国家族性乳腺癌BRCA1/2基因大片段重排断裂位点鉴定及功能研究
- 批准号:81772824
- 批准年份:2017
- 资助金额:60.0 万元
- 项目类别:面上项目
BRCA2基因肿瘤抑制新机制:抑制中心体过度复制
- 批准号:30771110
- 批准年份:2007
- 资助金额:30.0 万元
- 项目类别:面上项目
BACP1-BRCA2相互作用及其有丝分裂调控的研究
- 批准号:30470370
- 批准年份:2004
- 资助金额:21.0 万元
- 项目类别:面上项目
相似海外基金
Natural products inhibitors targeting homology-directed DNA repair for cancer therapy
针对癌症治疗的同源定向 DNA 修复的天然产物抑制剂
- 批准号:
10651048 - 财政年份:2023
- 资助金额:
$ 31.19万 - 项目类别:
Structure-Function Studies of a Cell Penetrating Antibody that Inhibits DNA Repair
抑制 DNA 修复的细胞穿透抗体的结构功能研究
- 批准号:
10633740 - 财政年份:2023
- 资助金额:
$ 31.19万 - 项目类别:
Shu complex and RAD52 function in DNA damage recognition and subsequent repair
Shu 复合物和 RAD52 在 DNA 损伤识别和后续修复中发挥作用
- 批准号:
10864084 - 财政年份:2023
- 资助金额:
$ 31.19万 - 项目类别:
Role of nuclear chaperones in genomic instability and carcinogenesis
核伴侣在基因组不稳定性和癌发生中的作用
- 批准号:
10529840 - 财政年份:2022
- 资助金额:
$ 31.19万 - 项目类别:
Mechanisms of RPA, Recombinases, and Mediators in Homologous Recombination
同源重组中 RPA、重组酶和介体的机制
- 批准号:
10589636 - 财政年份:2022
- 资助金额:
$ 31.19万 - 项目类别: